Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

News Feature: One for the money

Nature Medicine volume 11, pages 587–588 (2005)Cite this article

The US National Institutes of Health is set to pour up to $315 million more into HIV vaccine research over the next seven years. So why is the scientific community so angry? Apoorva Mandavilli investigates.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Get just this article for as long as you need it

$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Author information

Author notes

  1. Apoorva Mandavilli is Nature Medicine's senior news editor.

Authors
  1. Apoorva Mandavilli
    View author publications

    You can also search for this author in PubMed Google Scholar

Related links

Related links

Related links in Nature Research

http://www.nature.com/news/specials/aids/index.html

Related external links

CHAVI

Global HIV/AIDS Vaccine Enterprise Scientific Strategic Plan

Gates Foundation-HIV/AIDS

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Mandavilli, A. News Feature: One for the money. Nat Med 11, 587–588 (2005). https://doi.org/10.1038/nm0605-587

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm0605-587

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing